Literature DB >> 18086873

Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study.

Dan Ziegler1, Christian P Zentai, Siegfried Perz, Wolfgang Rathmann, Burkhard Haastert, Angela Döring, Christa Meisinger.   

Abstract

OBJECTIVES: To evaluate whether reduced heart rate variability (HRV), prolonged corrected QT (QTc) interval, or increased QT dispersion (QTD) are predictors of mortality in the general diabetic and nondiabetic population. RESEARCH DESIGN AND METHODS: Nondiabetic (n = 1,560) and diabetic (n = 160) subjects aged 55-74 years were assessed to determine whether reduced HRV, prolonged QTc interval, and increased QTD may predict all-cause mortality. Lowest quartiles for the maximum-minimum R-R interval difference (max-min, as measured at baseline from a 20-s standard 12-lead resting electrocardiogram without controlling for depth and rate of respiration), QTc >440 ms and QTD >60 ms, were used as cutpoints.
RESULTS: During a 9-year follow-up, 10.5% of the nondiabetic and 30.6% of the diabetic population deceased. In the nondiabetic individuals, multivariate Cox proportional hazard models adjusted for cardiovascular risk factors and demographic variables showed that prolonged QTc interval (hazard ratio 2.02 [95% CI 1.29-3.17]; P = 0.002) but not low max-min (0.93 [0.65-1.34]; P = 0.700), and increased QTD (0.98 [0.60-1.60]; P = 0.939) were associated with increased mortality. In the diabetic subjects, prolonged QTc was also a predictor of mortality (3.00 [1.34-6.71]; P = 0.007), while a trend for an increased risk was noted in those with low max-min (1.74 [0.95-3.18]; P = 0.075), whereas increased QTD did not predict mortality (0.42 [0.06-3.16]; P = 0.402).
CONCLUSIONS: Prolonged QTc interval, but not increased QTD, is an independent predictor of a twofold and threefold increased risk of mortality in the nondiabetic and diabetic elderly general population, respectively. Low HRV during spontaneous breathing tends to be associated with excess mortality in the diabetic but not nondiabetic population.

Entities:  

Mesh:

Year:  2007        PMID: 18086873     DOI: 10.2337/dc07-1615

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  64 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

2.  Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey.

Authors:  Dan Ziegler; Andreas Voss; Wolfgang Rathmann; Alexander Strom; Siegfried Perz; Michael Roden; Annette Peters; Christa Meisinger
Journal:  Diabetologia       Date:  2015-02-28       Impact factor: 10.122

Review 3.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

Review 4.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

5.  Heart Rate, Autonomic Function, and Future Changes in Glucose Metabolism in Individuals Without Diabetes: The Whitehall II Cohort Study.

Authors:  Christian Stevns Hansen; Kristine Færch; Marit Eika Jørgensen; Marek Malik; Daniel R Witte; Eric J Brunner; Adam G Tabák; Mika Kivimäki; Dorte Vistisen
Journal:  Diabetes Care       Date:  2019-04-02       Impact factor: 19.112

6.  QTc interval predicts outcome of catheter ablation in paroxysmal atrial fibrillation patients with type 2 diabetes mellitus.

Authors:  Ning Ma; Xiao-Yan Wu; Chang-Sheng Ma; Nian Liu; Rong Bai; Xin Du; Yan-Fei Ruan; Jian-Zeng Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

7.  Autonomic markers of impaired glucose metabolism: effects of sleep-disordered breathing.

Authors:  Wenli Wang; Susan Redline; Michael C K Khoo
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

8.  Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Rodica Pop-Busui; Gregory W Evans; Hertzel C Gerstein; Vivian Fonseca; Jerome L Fleg; Byron J Hoogwerf; Saul Genuth; Richard H Grimm; Marshall A Corson; Ronald Prineas
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

Review 9.  Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors:  Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

10.  Neuropathy: the crystal ball for cardiovascular disease?

Authors:  Aaron I Vinik; Raelene E Maser; Dan Ziegler
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.